Testing a new device to close PFO after stroke
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This trial tests a new device to close a PFO (a small hole in the heart) in people who have had a stroke caused by a blood clot passing through that hole. The goal is to see if the device can prevent another stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You had a stroke caused by a PFO (a hole between the upper chambers of your heart).
- Your PFO anatomy is suitable for the study device (evaluated by an independent committee).
- You are able to give informed consent and follow the study plan.
- You do not have other causes for your stroke, like heart disease or artery blockages.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device to close a PFO (a small hole between the upper chambers of the heart) in people who have had a stroke caused by a blood clot. The goal is to prevent future strokes by blocking the hole.
This trial tests whether closing a hole in the heart (a PFO) with a special device can help prevent another stroke after an unexplained stroke. You may be a candidate if your stroke likely happened because blood can pass through this PFO.
This trial looks at the safety and results of closing a PFO (a small hole in the heart) in people who have had a stroke or embolism with no other clear cause. If you qualify, doctors will close your PFO using a small tube inserted through a blood vessel and then follow your health over time.
This trial studies whether a Cera™ device is safe and effective for closing a patent foramen ovale (PFO), a small hole in the heart. It is for adults whose PFO is linked to certain types of stroke or ongoing clot-related events.
This trial compares two devices used to close a hole in the heart (called a PFO) in adults who have had a stroke or mini-stroke (TIA) within the last year. The goal is to see which device works better to prevent future strokes.
This study looks at whether closing a heart opening called a patent foramen ovale (PFO) with a special septal occluder, along with antiplatelet medications, can lower the risk of another stroke. It is for people who recently had a stroke thought to be caused by a clot that traveled from the heart but without another clear source.
Hear when a new PFO trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.